Skip to main content

Table 1 Demographic characteristics

From: The significance of immunonutrition nutritional support in patients undergoing postoperative adjuvant chemotherapy for lung cancer: case–control study

Variables

No. of patients (n = 81)

Frequency (%)

Sex

 Male

68

84

 Female

13

16

Age

  < 60 years (under 60 years of age)

32

39.5

  ≥ 60 years (aged 60 years and older)

49

60.5

 Mean age of patients (mean ± SD, range) (years)

61.81 ± 9.2 (38–81)

Comorbidities

 Cardiac

32

39.5

 Endocrinological

17

20.9

 Previous malignancy

16

19.7

 COPD

13

16

 Other

19

23.4

Complications

 Prolonged air leak

24

29.6

 Cardiac

8

9.8

 Blood product replacement

7

8.6

 Pneumonia

5

6.1

 Other

15

18.5

Surgical procedures

 RUL

19

23.5

 RML

1

1.2

 RLL

14

17.3

 RUBL

3

3.7

 RLBL

4

4.9

 LUL

6

7.4

 LLL

13

16

 RP

5

6.2

 LP

15

18.5

Histopathological diagnosis

 Adenocarcinoma

41

50.6

 Squamous cell carcinoma

40

49.4

Histopathological stage

 Stage IIA

6

7.4

 Stage IIB

41

50.6

 Stage IIIA

28

34.6

 Stage IIIB

6

7.4

Metastasis

 

18

22.2

Mortality

 

24

29.6

Nutritional status

 Nutritional supplement

46

56.8

 Normal diet

35

43.2

Mean length of hospital stay (LOS) (days)

8.26 ± 0.56 (3–27 ± 5.03)/days

  1. Abbreviations: COPD Chronic obstructive pulmonary disease, LLL Left lower lobectomy, LP Left pneumonectomy, LUL Left upper lobectomy, RLBL Right lower bilobectomy, RLL Right lower lobectomy, RML Right middle lobectomy, RP Right pneumonectomy, RUBL Right upper bilobectomy, RUL Right upper lobectomy